(1)
Effect of Spesolimab on Achieving Sustained Disease Remission in Patients With Generalized Pustular Psoriasis: Results from the Effisayil 2 Study. J of Skin 2024, 8 (2), s357. https://doi.org/10.25251/skin.8.supp.357.